![]() |
市場調查報告書
商品編碼
1433325
全球血液處理設備及耗材市場 2023-2030Global Blood Processing Devices and Consumables Market 2023-2030 |
由於需要輸血的疾病負擔增加、外科手術增加以及老年人口增加,預計全球血液處理設備和耗材市場在預測期內(2023-2030年)將以9.2%的CAGR成長。手術或其他輸血程序對安全血液供應的需求不斷成長表明了市場的成長。為了克服因輸血和捐血引起的感染,使用了多台血液處理機和血液處理耗材來預防感染。
全球血液處理設備和耗材市場依血液處理設備和耗材區隔。根據血液處理設備,市場區隔為血庫冷凍機、血液加溫器、血型分析儀、血庫冰箱、血球容積比離心機和血球處理器。此外,根據消耗品,市場區隔為採血針、小瓶、顯微鏡載玻片、血袋、輸血套件等。在消耗品中,由於醫院、血庫和其他醫療中心數量的增加,血袋區隔市場預計將佔據相當大的市場佔有率。此外,公民捐血意識的增強也推動了全球對血袋的需求。
在血液處理設備中,血球處理器子區隔市場預計將在全球血液處理設備和耗材市場中佔據相當大的佔有率。血球處理器是輸血醫學領域寶貴的救生程序之一。血球處理器採用基於離心機的技術將全血分離為其主要成分。血球處理器為分離細胞產品的勞動密集型技術提供了一種選擇,例如使用錐形管在密度梯度分離介質上手動分層血液。血球處理器用於血庫、輸血實驗室、細胞治療實驗室和製造設施。捐血數量的增加以及市場參與者推出新產品是推動該領域成長的主要因素。據世界衛生組織稱,全球每年收集約1.185億單位的捐捐血液,但還需要收集更多單位才能滿足全球所有患者的輸血需求。據報道,2008 年至 2018 年,自願無償捐血者的捐血量增加了 1,070 萬次。
全球血液處理設備和耗材市場根據地理位置進一步區隔,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲。其中,亞太地區預計將在全球市場中佔據顯著佔有率,由於醫療保健支出的增加以及中國和印度等國家改善醫療保健基礎設施的舉措推動了先進血液處理技術和耗材的採用。
在所有地區中,由於血癌病例的增加以及多個從事血液成分分配的組織的存在而產生了血液處理的需求,預計北美地區在預測期內將以相當大的CAGR成長。骨髓、血球、淋巴結和其他淋巴系統組成部分都可能受到白血病、淋巴瘤、骨髓瘤和骨髓增生異常綜合症 (MDS) 等癌症的影響。顯然,單採技術已被用來降低白血球計數,直到其他藥物能夠調節它。
根據白血病和淋巴瘤協會 (LLS) 的數據,到 2021 年,美國大約每三分鐘就有一人被診斷出患有血癌。大約每 9 分鐘,美國就有一人死於血癌。此外,該地區的組織致力於提高公民的捐血意識,也推動了對血液處理設備和耗材市場的需求。據估計,美國每年有 680 萬人捐血,每年收集 1,360 萬單位的全血和紅血球。
Global Blood Processing Devices and Consumables Market Size, Share & Trends Analysis Report by Blood Processing Devices (Blood Bank Freezers, Blood Warmers, Blood Grouping Analyzers, Blood Bank Refrigerators, Hematocrit Centrifuges and Blood Cell Processors), and by Consumables (Blood Lancets, Vials, Microscopic Slides, Blood Bags, Blood Administration Sets, and Others), Forecast Period (2023-2030)
The global blood processing devices and consumables market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030) owing to the rise burden of disorders requiring blood transfusion, increasing surgical procedures, as well as increasing geriatric population. The rising need for safe blood supply for surgeries or other transfusion procedures is shows market growth. To overcome the infections caused due to blood transfusions and blood donation, several blood processing machines and blood processing consumables are utilized to prevent infection.
The global blood processing devices and consumables market is segmented by the blood processing devices, and consumables. Based on the blood processing devices, the market is sub-segmented into blood bank freezers, blood warmers, blood grouping analyzers, blood bank refrigerators, hematocrit centrifuges and blood cell processors. Further, based on consumables, the market is sub-segmented into blood lancets, vials, microscopic slides, blood bags, blood administration sets, and others. Among the consumables, the blood bags sub-segment is anticipated to hold a considerable share of the market due to rising numbers of hospitals, blood banks, and other healthcare centers. Furthermore, the growing awareness about blood donation among citizens is also propelling the demand for blood bags, globally.
Among the blood processing devices, the blood cell processors sub-segment is expected to hold a considerable share of the global Blood Processing Devices and Consumables market. Blood cell processors is one of the precious lifesaving procedures in the field of transfusion medicine. Blood cell processors employs centrifuge-based technology to separate the whole blood into its major components. Blood cell processors provide an option to labor-intensive techniques for separating cell products, such as manually layering blood over a density gradient separation medium using conical tubes. Blood cell processors are used in blood banks, transfusion laboratories, cellular therapy laboratories, and manufacturing facilities. Increasing number of blood donations as well as the introduction of new products by the market players are major factors fueling the growth of the segment. According to WHO, around 118.5 million units of donated blood are collected globally every year, although more units would need to be collected to meet the needs of transfusion of all the patients in the globally. An increase of 10.7 million blood donations from voluntary unpaid donors has been reported from 2008 to 2018.
The global blood processing devices and consumables market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increasing healthcare expenditure and government initiatives to improve healthcare infrastructure in countries such as China and India drive the adoption of advanced blood processing technologies and consumables.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period due to the rising cases blood cancer and presence of several organizations engaged in the distribution of blood components that arises the need for blood processing. Bone marrow, blood cells, lymph nodes, and other lymphatic system components can all be impacted by cancers such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS). Apheresis technology has apparently been utilized to lower the white cell count until other drugs are able to regulate it.
According to the Leukemia and Lymphoma Society (LLS), approximately every three minutes, one person in the US is diagnosed with blood cancer in 2021. Approximately every 9 minutes, someone in the US dies from a blood cancer. Moreover, organizations in the region are engaged in growing awareness about blood donation among citizens is also propelling the demand for blood processing devices and consumables market. Each year, an estimated 6.8 million people in the U.S. donate blood and 13.6 million units of whole blood and red blood cells are collected in the U.S. in a year.
The major companies serving the global blood processing devices and consumables market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021, BD (Becton, Dickinson and Company), acquired Velano Vascular. The Velano Vascular acquisition is in line with BD's growth strategy to enter new categories that deal with unmet needs and have a more positive impact on patients and health systems. Velano Vascular offers an innovative, needle-free technology that enables high-quality blood drawn from existing peripheral intravenous catheter (PIVC) lines, BD can now enable health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort from the process while delivering quality outcomes